CCHFV vaccine development, current challenges, limitations, and future directions.
Crimean-Congo hemorrhagic fever virus
DNA-based vaccines
mRNA-based vaccines
vaccines
viral vectored vaccines
virus-like particle (VLP)
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
12
06
2023
accepted:
22
08
2023
medline:
28
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
Crimean-Congo hemorrhagic fever (CCHF) is the most prevalent tick-borne viral disease affecting humans. The disease is life-threatening in many regions of the developing world, including Africa, Asia, the Middle East, and Southern Europe. In line with the rapidly increasing disease prevalence, various vaccine strategies are under development. Despite a large number of potential vaccine candidates, there are no approved vaccines as of yet. This paper presents a detailed comparative analysis of current efforts to develop vaccines against CCHFV, limitations associated with current efforts, and future research directions.
Identifiants
pubmed: 37753088
doi: 10.3389/fimmu.2023.1238882
pmc: PMC10518622
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1238882Informations de copyright
Copyright © 2023 Ahata and Akçapınar.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Cell Infect Microbiol. 2023 Mar 21;13:1121163
pubmed: 37026060
PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005908
pubmed: 28922426
N Engl J Med. 1987 Feb 12;316(7):369-74
pubmed: 2433582
J Virol. 2022 Feb 9;96(3):e0156821
pubmed: 34817199
Biotechnol Genet Eng Rev. 2018 Apr;34(1):122-138
pubmed: 29781359
Acta Virol. 1973 Sep;17(5):409-15
pubmed: 4127707
Antiviral Res. 2004 Dec;64(3):145-60
pubmed: 15550268
Sci Rep. 2019 May 23;9(1):7755
pubmed: 31123310
BMC Med. 2023 Feb 1;21(1):36
pubmed: 36726141
Clin Vaccine Immunol. 2011 Dec;18(12):2031-7
pubmed: 22012978
Engineering (Beijing). 2022 Mar;10:127-132
pubmed: 35096437
Viruses. 2019 Mar 09;11(3):
pubmed: 30857305
Signal Transduct Target Ther. 2023 Apr 7;8(1):149
pubmed: 37029123
Lancet Infect Dis. 2006 Apr;6(4):203-14
pubmed: 16554245
Zoonoses Public Health. 2018 Aug;65(5):465-480
pubmed: 29676526
J Virol. 2015 Jun;89(11):5957-67
pubmed: 25810550
Front Med (Lausanne). 2022 Mar 04;9:829467
pubmed: 35308494
NPJ Vaccines. 2021 Mar 2;6(1):31
pubmed: 33654101
J Infect Dis. 2011 Nov;204 Suppl 3:S1075-81
pubmed: 21987744
FEBS Lett. 2019 Dec;593(24):3461-3483
pubmed: 31769012
Antiviral Res. 2019 Oct;170:104573
pubmed: 31377243
Nat Microbiol. 2018 May;3(5):556-562
pubmed: 29632370
Scand J Infect Dis. 2011 Mar;43(3):225-9
pubmed: 21142621
Comput Biol Med. 2021 Dec 2;140:105098
pubmed: 34875407
Nat Microbiol. 2021 Feb;6(2):187-195
pubmed: 33257849
PLoS One. 2016 Jun 07;11(6):e0156637
pubmed: 27272940
PLoS Negl Trop Dis. 2015 Mar 11;9(3):e0003579
pubmed: 25760444
J Gen Virol. 2010 Jun;91(Pt 6):1473-7
pubmed: 20164263
Mol Cell Biol. 1983 Dec;3(12):2156-65
pubmed: 6318086
Proc Natl Acad Sci U S A. 1972 Oct;69(10):2904-9
pubmed: 4342968
Hum Vaccin Immunother. 2016;12(2):519-27
pubmed: 26309231
Sci Rep. 2022 May 24;12(1):8736
pubmed: 35610299
Vaccine. 2012 Sep 28;30(44):6225-9
pubmed: 22902680
Infect Drug Resist. 2021 Dec 09;14:5271-5285
pubmed: 34916811
J Virol. 2006 Sep;80(17):8834-42
pubmed: 16912331
J Infect Dis. 2017 Dec 12;216(11):1386-1397
pubmed: 28482001
EBioMedicine. 2023 Apr;90:104523
pubmed: 36933409
PLoS One. 2008 Jul 16;3(7):e2685
pubmed: 18628832
Acta Biomater. 2018 Oct 15;80:31-47
pubmed: 30172933
Virol J. 2010 Oct 20;7:279
pubmed: 20961433
Mol Ther. 2023 Feb 1;31(2):387-397
pubmed: 36184852
Antiviral Res. 2017 Oct;146:112-120
pubmed: 28842265
Science. 1990 Mar 23;247(4949 Pt 1):1465-8
pubmed: 1690918
Vector Borne Zoonotic Dis. 2015 Dec;15(12):759-64
pubmed: 26684523
Heliyon. 2021 Oct 12;7(10):e08161
pubmed: 34703927
Viruses. 2016 Apr 21;8(4):106
pubmed: 27110812
Curr Opin Immunol. 2016 Aug;41:47-54
pubmed: 27286566
Expert Rev Vaccines. 2010 Oct;9(10):1149-76
pubmed: 20923267
Vaccine. 2017 Oct 20;35(44):6015-6023
pubmed: 28687403
Viruses. 2022 Jul 28;14(8):
pubmed: 36016285
Vaccines (Basel). 2019 Sep 16;7(3):
pubmed: 31527460
Vaccine. 2006 May 22;24(21):4657-66
pubmed: 16174542
Vaccines (Basel). 2020 Apr 14;8(2):
pubmed: 32295153
PLoS Pathog. 2019 Sep 26;15(9):e1008050
pubmed: 31557262
Viruses. 2016 Oct 28;8(11):
pubmed: 27801824
J Med Entomol. 1979 May 22;15(4):307-417
pubmed: 113533
J Biomed Inform. 2019 May;93:103160
pubmed: 30928513
Vaccines (Basel). 2020 Mar 02;8(1):
pubmed: 32131403
Int J Biol Macromol. 2021 Dec 15;193(Pt A):574-584
pubmed: 34699894
Sci Adv. 2019 Jul 10;5(7):eaaw9535
pubmed: 31309159
PLoS One. 2014 Mar 12;9(3):e91516
pubmed: 24621656
Emerg Microbes Infect. 2019;8(1):575-578
pubmed: 30947619
Mol Cell Probes. 2021 Feb;55:101693
pubmed: 33388416
Virus Res. 2004 Jun 15;102(2):185-9
pubmed: 15084400
Nat Rev Drug Discov. 2021 Nov;20(11):817-838
pubmed: 34433919
Curr Opin Biotechnol. 1997 Oct;8(5):635-46
pubmed: 9353234
J Virol. 2007 Oct;81(20):10869-78
pubmed: 17670815
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209
pubmed: 34488546
Antiviral Res. 2013 Oct;100(1):159-89
pubmed: 23906741
J Gen Virol. 2015 Jan;96(Pt 1):6-23
pubmed: 25246703
Nat Biotechnol. 2021 Dec;39(12):1479-1482
pubmed: 34785814
Adv Virus Res. 2017;97:187-243
pubmed: 28057259
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006628
pubmed: 30011277
Expert Rev Vaccines. 2018 Sep;17(9):833-849
pubmed: 30173619
Drug Metab Pharmacokinet. 2022 Feb;42:100432
pubmed: 34974335
Adv Genet. 2012;78:1-167
pubmed: 22980921
Curr Opin Biotechnol. 2007 Dec;18(6):546-56
pubmed: 18063357
Appl Environ Microbiol. 2006 Jan;72(1):880-9
pubmed: 16391130
Intervirology. 1999;42(2-3):117-24
pubmed: 10516466
Vaccine. 2012 Feb 27;30(10):1759-66
pubmed: 22265860
EBioMedicine. 2022 Aug;82:104188
pubmed: 35907368
Front Immunol. 2019 Mar 27;10:594
pubmed: 30972078
NPJ Vaccines. 2022 Jul 4;7(1):75
pubmed: 35787629
Intervirology. 2013;56(3):141-65
pubmed: 23594863
J Infect Dis. 2013 Jun 15;207(12):1909-21
pubmed: 23417661
PLoS Negl Trop Dis. 2020 Aug 13;14(8):e0008637
pubmed: 32790668
Vaccines (Basel). 2021 Dec 20;9(12):
pubmed: 34960250
J Virol. 2005 May;79(10):6152-61
pubmed: 15858000
Viruses. 2019 Jan 17;11(1):
pubmed: 30658445
Antiviral Res. 2017 Aug;144:93-119
pubmed: 28579441
J Virol. 2017 Apr 28;91(10):
pubmed: 28250124
J Prev Med Hyg. 2016 Sep;57(3):E115-E120
pubmed: 27980374
J Biol Chem. 2016 Jan 8;291(2):582-92
pubmed: 26574543
J Virol. 2010 Nov;84(21):11089-100
pubmed: 20739514
Life Sci. 2021 Feb 15;267:118919
pubmed: 33352173